TrialsAlert vs CenterWatch
Patient briefings vs industry intelligence
By Victor Lafforgue, Founder of TrialsAlert. Last updated March 2026. TrialsAlert is our product.
What is CenterWatch?
CenterWatch is a clinical trial information platform that has served the clinical research industry since 1994. It provides access to over 40,000 clinical trial listings updated daily, along with industry intelligence including benchmark reports, regulatory guidance, training resources, and thought leadership content. CenterWatch serves a dual audience: patients can browse trial listings, while industry professionals access premium reports and training materials.
How is TrialsAlert different from CenterWatch?
CenterWatch is primarily an industry information platform that also offers patient-facing trial listings. TrialsAlert is built exclusively for patients and caregivers. The difference shows in every design decision: TrialsAlert explains trials in plain language, classifies them by patient impact (not industry metrics), delivers proactive weekly briefings (no searching required), and generates reports formatted for patient-doctor conversations. CenterWatch's strength is industry intelligence — benchmark reports, FDA guidance, and operational insights.
Who should use which?
If you are a patient or caregiver who wants to stay informed about research for a specific condition without spending hours searching, TrialsAlert is purpose-built for you. If you work in the clinical research industry and need benchmark data, regulatory updates, or training resources, CenterWatch provides that. If you want to browse trial listings yourself, CenterWatch offers that for free — but without the AI classification, weekly briefings, or doctor reports that TrialsAlert provides.